The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s lung cancer drugs market report forecasts the lung cancer drugs market size to grow to $54.43 Billion by 2027, with a CAGR (compound annual growth rate) of more than 10%.

Learn More On The Lung Cancer Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

Lung Cancer Drugs Market Size Forecast
The global lung cancer drugs market is expected to grow from $32.67 billion in 2022 to $36.53 billion in 2023 at a compound annual growth rate (CAGR) of 11.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global lung cancer drugs market size is expected to grow to $54.43 billion in 2027 at a CAGR of 10.5%.

North America held the largest lung cancer drugs market share, and Middle East was the fastest-growing region in 2022.

Key Lung Cancer Drugs Market Driver ­– Rise In The Prevalence Rate Of Lung Cancer
According to the World Health Organization report, cancer led to around 10 million deaths in 2020, out of which, lung cancer was responsible for the largest number of deaths (1.80 million deaths).

Request for A Sample Of The Global Lung Cancer Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2567&type=smp

Key Lung Cancer Drugs Market Trend – Developing Targeted Drug Therapy In Combination With Other Therapies
It involves the use of immunotherapy drugs combined with other therapies such as chemotherapy that help in early diagnosis, prevention, and treatment of the disease. In this regard, drug manufacturers are developing targeted drug therapies for better diagnosis and treatment of lung cancer. For example, Merck and Co. developed pembrolizumab, which is a drug that helps the immune system to detect and fight cancer cells when used in addition to chemotherapy. This combination therapy showed an improvement in lung cancer status in patients. The drug is a major product of Merck and Co. and is sold under the brand name Keytruda.

Lung Cancer Drugs Market Segment
1) By Disease Type: Small cell lung cancer (SCLC), Non-small cell lung cancer (NSCLC)
2) By End User: Hospitals, Clinics, Other End-Users
3) By Drugs: Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs

Lung Cancer Drugs Market Major Players and Strategies
Major players in the lung cancer drugs market are Bristol-Myers Squibb Company, Merck & Co., F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., GlaxoSmithKlin, Vertiv Co., Sanofi-Aventis, Sun Pharmaceuticals Industries and Celgene Corporation.

The Lung Cancer Drugs Global Market Report 2023 covers regional data on lung cancer drugs market size, lung cancer drugs market trends and drivers, opportunities, strategies, and lung cancer drugs market competitor analysis. The countries covered in the lung cancer drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Lung cancer drugs refer to anti-angiogenic drugs that are used to treat lung cancer. Lung cancer is a type of cancer that decreases the ability of the lungs to supply oxygen to the bloodstream because of the uncontrolled growth of tissues in the lung. Some of the possible treatments for lung cancer include surgery, chemotherapy, radiation therapy, and targeted therapy. Based on the size of the tumor cells, lung cancer is broadly divided into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).

View More Reports Related To The Lung Cancer Drugs Market –
Kidney Cancer Drugs Global Market Report 2023
Skin Cancer Drugs Global Market Report 2023
Pancreatic Cancer Drugs Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: